REBAMIPIDE

作品数:21被引量:58H指数:5
导出分析报告
相关领域:医药卫生更多>>
相关期刊:《国外新药介绍》《外文科技期刊数据库(文摘版)医药卫生》《World Journal of Gastroenterology》《World Journal of Gastrointestinal Pharmacology and Therapeutics》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Rebamipide in gastric mucosal protection and healing:An Asian perspective
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2025年第1期25-36,共12页Manish Kak 
This review emphasizes the exemplary safety and efficacy of rebamipide in the treatment of gastric ulcers and other mucosa-related disorders,positioning it as a viable candidate for inclusion in treatment guidelines a...
关键词:REBAMIPIDE Peptic ulcer Gastroesophageal reflux disease Mucosal protection TREATMENT 
Efficacy and safety of rebamipide/nizatidine in patients with erosive gastritis: A randomized, multicenter, phase 4 study
《World Journal of Gastroenterology》2024年第48期5152-5161,共10页Donghoon Kang Myung-Gyu Choi Ki-Nam Shim Hye-Kyung Jung Seung-Joo Nam Jung Ho Park Sang Gyun Kim Nam-Hoon Kim Su Jin Hong Tae Joo Jeon Jae Il Chung Hang Lak Lee Ju Yup Lee Tae Oh Kim Chang Min Lee Sun Moon Kim Jeong-Hwan Kim Jang Eon Kim Jeong Seop Moon Ho Dong Kim Wan-Sik Lee Hong Jun Park 
BACKGROUND For the treatment of gastritis,rebamipide,a mucoprotective agent,and nizatidine,a gastric acid suppressant,are commonly employed individually.AIM To compare the efficacy of Mucotra®SR(rebamipide 150 mg)and ...
关键词:GASTRITIS Erosive gastritis Combination therapy REBAMIPIDE NIZATIDINE 
Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis:A matching-adjusted indirect comparison被引量:1
《World Journal of Clinical Cases》2024年第19期3890-3897,共8页Gwang Ha Kim Hang Lak Lee 
BACKGROUND Gastritis is one of the most frequently diagnosed diseases requiring medical treatment in South Korea.Fexuprazan,a novel potassium-competitive acid blocker,has been approved for treating gastritis and erosi...
关键词:GASTRITIS Erosive gastritis Fexuprazan REBAMIPIDE Matching-adjusted indirect comparison Indirect treatment comparison 
Evaluation of the Efficacy and Safety of Triple Therapy Combined with Rebamipide in the Treatment of Senile Peptic Gastric Ulcer
《外文科技期刊数据库(文摘版)医药卫生》2021年第12期428-432,共8页WANG Tingting WAN Panting 
Objective: to systematically evaluate the efficacy and safety of triple therapy combined with rebapat in the treatment of elderly patients with peptic gastric ulcer. Methods: embase, PubMed, Cochrane library, CNKI, Wa...
关键词:triple therapy rebapat peptic ulcer meta analysis sequential analysis of tests 
Protective mechanism of rebamipide on non-steroid anti-inflammatory drug related small intestinal mucosal injury
《China Medical Abstracts(Internal Medicine)》2021年第3期171-172,共2页HAN Taotao 
Objective To explore the protective effect and related mechanism of rebamipide on nonsteroid anti-inflammatory drug(NSAID)related small intestinal mucosal injury.Methods A total of 21 C57BL/6 mice were selected and by...
关键词:C57BL/6 DRUG NSAID INFLAMMATORY 
Rebamipide and Pantoprazole Combination in NSAIDs-Gastropathy Treatment
《Journal of Pharmacy and Pharmacology》2017年第3期153-157,共5页Maher Mbarki Helen Sklyarova Krystyna Aksentiychuk1 Natalia Kharchenko Eugene Sklyarov 
The objective of this study was to investigate the pantoprazole and rebamipide efficiency on NSAIDs (nonsteroidal anti-inflammatory drugs)-gastropathy restoring and healing in patients with coronary heart disease, s...
关键词:NSAIDS acetylsalicylic acid PANTOPRAZOLE REBAMIPIDE GASTROPATHY LTB4 PGE2. 
Enhanced bioavailability of rebamipide nanocrystal tablets:Formulation and in vitro/in vivo evaluation被引量:2
《Asian Journal of Pharmaceutical Sciences》2015年第3期223-229,共7页Yu Guo Yongjun Wang Lu Xu 
The purpose of this study was to formulate rebamipide nanocrystal tablets(REB-NTs)by wet-milling technique to enhance its dissolution rate and oral bioavailability.The formulation and preparation technology were scree...
关键词:REBAMIPIDE Nanocrystal DISSOLUTION PHARMACOKINETICS 
Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers被引量:6
《World Journal of Gastroenterology》2014年第43期16318-16322,共5页Makoto Arai Tomoaki Matsumura Kenichiro Okimoto Arata Oyamada Keiko Saito Shoko Minemura Daisuke Maruoka Takeshi Tanaka Tomoo Nakagawa Tatsuro Katsuno Osamu Yokosuka 
Supported by Grant support from Daiichi Sankyo Co.,Ltd.,Astra Zeneca Co.,Ltd.,and Otsuka Pharmaceutical Co.,Ltd(To Yokosuka O);the lecture fees from Daiichi Sankyo,AstraZeneca(To Arai M)
AIM: To investigate the optimum period of treatment for post endoscopic submucosal dissection (ESD) ulcers.
关键词:Proton pump inhibitor Endoscopic submucosal dissection ESOMEPRAZOLE REBAMIPIDE Randomized control trial 
Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers被引量:15
《World Journal of Gastroenterology》2013年第34期5706-5712,共7页Masaki Takayama Shigenaga Matsui Masanori Kawasaki Yutaka Asakuma Toshiharu Sakurai Hiroshi Kashida Masatoshi Kudo 
AIM:To prospectively compare the healing rates of endoscopic submucosal dissection(ESD)-induced ulcers treated with either a proton-pump inhibitor(PPI)or rebamipide.METHODS:We examined 90 patients with early gastric c...
关键词:Early GASTRIC cancer REBAMIPIDE Endoscopic SUBMUCOSAL DISSECTION GASTRIC ULCER Protonpump inhibitor 
Anti free radical &anti inflammatory effect of rebamipide in chronic gastritis
《Open Journal of Gastroenterology》2013年第1期72-77,共6页Marcellus Simadibrata Ari Fahrial Syam Aziz Rani Septelia Inawati Wanandi Achmad Fauzi Murdani Abdullah 
Background/Aim: Free radicals have a role in the development of chronic gastritis. The aim of this study to know the effect and efficacy of rebamipide on free radicals in chronic gastritis. Method: Forty five patients...
关键词:REBAMIPIDE Chronic GASTRITIS Histopathologic SEVERITY MDA CARBONYL Compound 
检索报告 对象比较 聚类工具 使用帮助 返回顶部